Informal norms in global governance: human rights, intellectual property rules and access to medicines
Gespeichert in:
1. Verfasser: | |
---|---|
Format: | Elektronisch E-Book |
Sprache: | English |
Veröffentlicht: |
Farnham, Surrey, England
Ashgate
©2013
|
Schriftenreihe: | Global health
|
Schlagworte: | |
Online-Zugang: | FAW01 FAW02 |
Beschreibung: | Includes bibliographical references (pages 199-229) and index Cover; Contents; List of Figures and Tables; Foreword; Preface; List of Abbreviations; 1 Introduction; (a) Formal and informal norms in the governance of a global society; (b) The emergence of the "access to medicines" norm; (c) Informal norms and human rights; (d) Overview of the book; 2 Towards a Global Society; (a) Globalization; (b) From international relations to global governance; (c) Transnational actors in global governance; (d) Post-Westphalian global health governance (E) Interfaces, nodal governance, and polylateral diplomacy: Elements of the social construction of global health governance (GHG)(f) Global society, global politics and human rights; 3 Access to Medicines: A Matter of Human Rights; (a) The right to health and to access to essential medicines; (b) Sources of formal and informal norms on access to medicines; (c) The UN Special Rapporteur on the Right to Health; 4 Access to Medicines and Intellectual Property; (a) Medicines and the global public goods problem; (b) Introducing the WTO; (c) Introduction to TRIPS-basic issues (D) TRIPS, TRIPS+ and the fight for social issues5 The HIV/AIDS Crisis: The Rise of the Access Norm; (a) A brief introduction to HIV/AIDS medicines; (b) AIDS treatment and IP rules in the developing world: The special role of Brazil; (c) A window of opportunity: The 1999-2001 "policy crisis"; (d) The Doha Declaration on the TRIPS Agreement and Public Health; (e) Early debates on disease scope: The WTO medicines (6) decision and the TRIPS amendment; (f) Improved access to medicines: Using TRIPS flexibilities; (g) The first developing country compulsory licenses: Zimbabwe and Malaysia (H) Thailand: Regularizing the use of compulsory licensing(i) Role and character of finance for treatment; (j) The rise of access to medicines: Timeline of decisions and increased use of compulsory licensing, 2001-2010; 6 Beyond HIV in Africa: Solidification and Expansion of the Access Norm; (a) Solidification of the access norm; (b) Inclusiveness of the access norm: Which medicines are essential?; (c) The inclusiveness of the access norm: Middle-income countries as the new battlefield?; 7 Challenges to the Stability of Informal Norms; (a) Challenges in access to HIV/AIDS medicines (B) Free trade agreements(c) WTO accession agreements; (d) Alternate channels for IP rulemaking; 8 Re-framing the Access Norm: Incorporating Innovation; (a) From expert commissions to global strategies; (b) Innovation and access: I+A; (c) Changing expectations for the MICs: Contributions to R & D; 9 The Impact of Non-state Actors on Informal Norms: Nodal Governance and Global Democracy; (a) Nodal governance and informal norm-building; (b) Nodal governance: Interfaces between IGOs, governments and non-state actors in global politics; (c) Role and power of non-state actors in global norm-building Hein and Moon take up a serious problem of contemporary global governance: what can be done when international trade rules prevent the realization of basic human rights? This book recounts the remarkable story of the access to medicines movement and offers an explanation for how the "access norm" emerged against long odds. It also explores the stability and scope of the norm with respect to other diseases and emerging economies. Finally, in light of the high barriers to changing formal global trade rules, the book considers the potential and limitations of informal norms for protecting human r |
Beschreibung: | xviii, 241 pages |
ISBN: | 9781409426349 1409426343 9781409470908 1409470903 1283901919 9781283901918 9781409426332 1409426335 |
Internformat
MARC
LEADER | 00000nmm a2200000zc 4500 | ||
---|---|---|---|
001 | BV043787102 | ||
003 | DE-604 | ||
005 | 00000000000000.0 | ||
007 | cr|uuu---uuuuu | ||
008 | 160920s2013 |||| o||u| ||||||eng d | ||
020 | |a 9781409426349 |9 978-1-4094-2634-9 | ||
020 | |a 1409426343 |9 1-4094-2634-3 | ||
020 | |a 9781409470908 |9 978-1-4094-7090-8 | ||
020 | |a 1409470903 |9 1-4094-7090-3 | ||
020 | |a 1283901919 |9 1-283-90191-9 | ||
020 | |a 9781283901918 |9 978-1-283-90191-8 | ||
020 | |a 9781409426332 |9 978-1-4094-2633-2 | ||
020 | |a 1409426335 |9 1-4094-2633-5 | ||
035 | |a (ZDB-4-EBA)ocn828893564 | ||
035 | |a (OCoLC)828893564 | ||
035 | |a (DE-599)BVBBV043787102 | ||
040 | |a DE-604 |b ger |e aacr | ||
041 | 0 | |a eng | |
049 | |a DE-1046 |a DE-1047 | ||
082 | 0 | |a 362.1 |2 23 | |
100 | 1 | |a Hein, Wolfgang |d 1949- |e Verfasser |4 aut | |
245 | 1 | 0 | |a Informal norms in global governance |b human rights, intellectual property rules and access to medicines |c Wolfgang Hein, Suerie Moon |
264 | 1 | |a Farnham, Surrey, England |b Ashgate |c ©2013 | |
300 | |a xviii, 241 pages | ||
336 | |b txt |2 rdacontent | ||
337 | |b c |2 rdamedia | ||
338 | |b cr |2 rdacarrier | ||
490 | 0 | |a Global health | |
500 | |a Includes bibliographical references (pages 199-229) and index | ||
500 | |a Cover; Contents; List of Figures and Tables; Foreword; Preface; List of Abbreviations; 1 Introduction; (a) Formal and informal norms in the governance of a global society; (b) The emergence of the "access to medicines" norm; (c) Informal norms and human rights; (d) Overview of the book; 2 Towards a Global Society; (a) Globalization; (b) From international relations to global governance; (c) Transnational actors in global governance; (d) Post-Westphalian global health governance | ||
500 | |a (E) Interfaces, nodal governance, and polylateral diplomacy: Elements of the social construction of global health governance (GHG)(f) Global society, global politics and human rights; 3 Access to Medicines: A Matter of Human Rights; (a) The right to health and to access to essential medicines; (b) Sources of formal and informal norms on access to medicines; (c) The UN Special Rapporteur on the Right to Health; 4 Access to Medicines and Intellectual Property; (a) Medicines and the global public goods problem; (b) Introducing the WTO; (c) Introduction to TRIPS-basic issues | ||
500 | |a (D) TRIPS, TRIPS+ and the fight for social issues5 The HIV/AIDS Crisis: The Rise of the Access Norm; (a) A brief introduction to HIV/AIDS medicines; (b) AIDS treatment and IP rules in the developing world: The special role of Brazil; (c) A window of opportunity: The 1999-2001 "policy crisis"; (d) The Doha Declaration on the TRIPS Agreement and Public Health; (e) Early debates on disease scope: The WTO medicines (6) decision and the TRIPS amendment; (f) Improved access to medicines: Using TRIPS flexibilities; (g) The first developing country compulsory licenses: Zimbabwe and Malaysia | ||
500 | |a (H) Thailand: Regularizing the use of compulsory licensing(i) Role and character of finance for treatment; (j) The rise of access to medicines: Timeline of decisions and increased use of compulsory licensing, 2001-2010; 6 Beyond HIV in Africa: Solidification and Expansion of the Access Norm; (a) Solidification of the access norm; (b) Inclusiveness of the access norm: Which medicines are essential?; (c) The inclusiveness of the access norm: Middle-income countries as the new battlefield?; 7 Challenges to the Stability of Informal Norms; (a) Challenges in access to HIV/AIDS medicines | ||
500 | |a (B) Free trade agreements(c) WTO accession agreements; (d) Alternate channels for IP rulemaking; 8 Re-framing the Access Norm: Incorporating Innovation; (a) From expert commissions to global strategies; (b) Innovation and access: I+A; (c) Changing expectations for the MICs: Contributions to R & D; 9 The Impact of Non-state Actors on Informal Norms: Nodal Governance and Global Democracy; (a) Nodal governance and informal norm-building; (b) Nodal governance: Interfaces between IGOs, governments and non-state actors in global politics; (c) Role and power of non-state actors in global norm-building | ||
500 | |a Hein and Moon take up a serious problem of contemporary global governance: what can be done when international trade rules prevent the realization of basic human rights? This book recounts the remarkable story of the access to medicines movement and offers an explanation for how the "access norm" emerged against long odds. It also explores the stability and scope of the norm with respect to other diseases and emerging economies. Finally, in light of the high barriers to changing formal global trade rules, the book considers the potential and limitations of informal norms for protecting human r | ||
650 | 4 | |a Public Health | |
650 | 4 | |a Developing Countries | |
650 | 4 | |a Human Rights | |
650 | 4 | |a International Cooperation | |
650 | 4 | |a Patents as Topic | |
650 | 4 | |a Pharmaceutical Preparations / economics | |
650 | 4 | |a Drugs / Prices / Developing countries | |
650 | 4 | |a Foreign trade regulation / Developing countries | |
650 | 4 | |a Patents (International law) | |
650 | 4 | |a Public health / International cooperation | |
650 | 4 | |a Right to health / Developing countries | |
650 | 7 | |a HEALTH & FITNESS / Diseases / General |2 bisacsh | |
650 | 7 | |a HEALTH & FITNESS / Health Care Issues |2 bisacsh | |
650 | 7 | |a MEDICAL / Diseases |2 bisacsh | |
650 | 7 | |a MEDICAL / Health Care Delivery |2 bisacsh | |
650 | 7 | |a MEDICAL / Health Policy |2 bisacsh | |
650 | 7 | |a MEDICAL / Public Health |2 bisacsh | |
650 | 7 | |a SOCIAL SCIENCE / Disease & Health Issues |2 bisacsh | |
650 | 7 | |a Drugs / Prices |2 fast | |
650 | 7 | |a Foreign trade regulation |2 fast | |
650 | 7 | |a Patents (International law) |2 fast | |
650 | 7 | |a Public health / International cooperation |2 fast | |
650 | 7 | |a Right to health |2 fast | |
650 | 4 | |a Entwicklungsländer | |
650 | 4 | |a Medizin | |
650 | 4 | |a Public health |x International cooperation | |
650 | 4 | |a Right to health |z Developing countries | |
650 | 4 | |a Drugs |x Prices |z Developing countries | |
650 | 4 | |a Foreign trade regulation |z Developing countries | |
650 | 4 | |a Patents (International law) | |
650 | 0 | 7 | |a Medizinische Versorgung |0 (DE-588)4038270-9 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Außenhandelspolitik |0 (DE-588)4003841-5 |2 gnd |9 rswk-swf |
651 | 7 | |a Entwicklungsländer |0 (DE-588)4014954-7 |2 gnd |9 rswk-swf | |
689 | 0 | 0 | |a Entwicklungsländer |0 (DE-588)4014954-7 |D g |
689 | 0 | 1 | |a Medizinische Versorgung |0 (DE-588)4038270-9 |D s |
689 | 0 | 2 | |a Außenhandelspolitik |0 (DE-588)4003841-5 |D s |
689 | 0 | |8 1\p |5 DE-604 | |
700 | 1 | |a Moon, Suerie |e Sonstige |4 oth | |
912 | |a ZDB-4-EBA | ||
999 | |a oai:aleph.bib-bvb.de:BVB01-029198161 | ||
883 | 1 | |8 1\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
966 | e | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=504495 |l FAW01 |p ZDB-4-EBA |q FAW_PDA_EBA |x Aggregator |3 Volltext | |
966 | e | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=504495 |l FAW02 |p ZDB-4-EBA |q FAW_PDA_EBA |x Aggregator |3 Volltext |
Datensatz im Suchindex
_version_ | 1804176623500525568 |
---|---|
any_adam_object | |
author | Hein, Wolfgang 1949- |
author_facet | Hein, Wolfgang 1949- |
author_role | aut |
author_sort | Hein, Wolfgang 1949- |
author_variant | w h wh |
building | Verbundindex |
bvnumber | BV043787102 |
collection | ZDB-4-EBA |
ctrlnum | (ZDB-4-EBA)ocn828893564 (OCoLC)828893564 (DE-599)BVBBV043787102 |
dewey-full | 362.1 |
dewey-hundreds | 300 - Social sciences |
dewey-ones | 362 - Social problems and services to groups |
dewey-raw | 362.1 |
dewey-search | 362.1 |
dewey-sort | 3362.1 |
dewey-tens | 360 - Social problems and services; associations |
discipline | Soziologie |
format | Electronic eBook |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>07186nmm a2200961zc 4500</leader><controlfield tag="001">BV043787102</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">160920s2013 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781409426349</subfield><subfield code="9">978-1-4094-2634-9</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1409426343</subfield><subfield code="9">1-4094-2634-3</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781409470908</subfield><subfield code="9">978-1-4094-7090-8</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1409470903</subfield><subfield code="9">1-4094-7090-3</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1283901919</subfield><subfield code="9">1-283-90191-9</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781283901918</subfield><subfield code="9">978-1-283-90191-8</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781409426332</subfield><subfield code="9">978-1-4094-2633-2</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1409426335</subfield><subfield code="9">1-4094-2633-5</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-4-EBA)ocn828893564</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)828893564</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV043787102</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-1046</subfield><subfield code="a">DE-1047</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">362.1</subfield><subfield code="2">23</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Hein, Wolfgang</subfield><subfield code="d">1949-</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Informal norms in global governance</subfield><subfield code="b">human rights, intellectual property rules and access to medicines</subfield><subfield code="c">Wolfgang Hein, Suerie Moon</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Farnham, Surrey, England</subfield><subfield code="b">Ashgate</subfield><subfield code="c">©2013</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">xviii, 241 pages</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Global health</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references (pages 199-229) and index</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Cover; Contents; List of Figures and Tables; Foreword; Preface; List of Abbreviations; 1 Introduction; (a) Formal and informal norms in the governance of a global society; (b) The emergence of the "access to medicines" norm; (c) Informal norms and human rights; (d) Overview of the book; 2 Towards a Global Society; (a) Globalization; (b) From international relations to global governance; (c) Transnational actors in global governance; (d) Post-Westphalian global health governance</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">(E) Interfaces, nodal governance, and polylateral diplomacy: Elements of the social construction of global health governance (GHG)(f) Global society, global politics and human rights; 3 Access to Medicines: A Matter of Human Rights; (a) The right to health and to access to essential medicines; (b) Sources of formal and informal norms on access to medicines; (c) The UN Special Rapporteur on the Right to Health; 4 Access to Medicines and Intellectual Property; (a) Medicines and the global public goods problem; (b) Introducing the WTO; (c) Introduction to TRIPS-basic issues</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">(D) TRIPS, TRIPS+ and the fight for social issues5 The HIV/AIDS Crisis: The Rise of the Access Norm; (a) A brief introduction to HIV/AIDS medicines; (b) AIDS treatment and IP rules in the developing world: The special role of Brazil; (c) A window of opportunity: The 1999-2001 "policy crisis"; (d) The Doha Declaration on the TRIPS Agreement and Public Health; (e) Early debates on disease scope: The WTO medicines (6) decision and the TRIPS amendment; (f) Improved access to medicines: Using TRIPS flexibilities; (g) The first developing country compulsory licenses: Zimbabwe and Malaysia</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">(H) Thailand: Regularizing the use of compulsory licensing(i) Role and character of finance for treatment; (j) The rise of access to medicines: Timeline of decisions and increased use of compulsory licensing, 2001-2010; 6 Beyond HIV in Africa: Solidification and Expansion of the Access Norm; (a) Solidification of the access norm; (b) Inclusiveness of the access norm: Which medicines are essential?; (c) The inclusiveness of the access norm: Middle-income countries as the new battlefield?; 7 Challenges to the Stability of Informal Norms; (a) Challenges in access to HIV/AIDS medicines</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">(B) Free trade agreements(c) WTO accession agreements; (d) Alternate channels for IP rulemaking; 8 Re-framing the Access Norm: Incorporating Innovation; (a) From expert commissions to global strategies; (b) Innovation and access: I+A; (c) Changing expectations for the MICs: Contributions to R & D; 9 The Impact of Non-state Actors on Informal Norms: Nodal Governance and Global Democracy; (a) Nodal governance and informal norm-building; (b) Nodal governance: Interfaces between IGOs, governments and non-state actors in global politics; (c) Role and power of non-state actors in global norm-building</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Hein and Moon take up a serious problem of contemporary global governance: what can be done when international trade rules prevent the realization of basic human rights? This book recounts the remarkable story of the access to medicines movement and offers an explanation for how the "access norm" emerged against long odds. It also explores the stability and scope of the norm with respect to other diseases and emerging economies. Finally, in light of the high barriers to changing formal global trade rules, the book considers the potential and limitations of informal norms for protecting human r</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Public Health</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Developing Countries</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Human Rights</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">International Cooperation</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Patents as Topic</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmaceutical Preparations / economics</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drugs / Prices / Developing countries</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Foreign trade regulation / Developing countries</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Patents (International law)</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Public health / International cooperation</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Right to health / Developing countries</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">HEALTH & FITNESS / Diseases / General</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">HEALTH & FITNESS / Health Care Issues</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Diseases</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Health Care Delivery</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Health Policy</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Public Health</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">SOCIAL SCIENCE / Disease & Health Issues</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Drugs / Prices</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Foreign trade regulation</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Patents (International law)</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Public health / International cooperation</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Right to health</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Entwicklungsländer</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medizin</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Public health</subfield><subfield code="x">International cooperation</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Right to health</subfield><subfield code="z">Developing countries</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drugs</subfield><subfield code="x">Prices</subfield><subfield code="z">Developing countries</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Foreign trade regulation</subfield><subfield code="z">Developing countries</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Patents (International law)</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Medizinische Versorgung</subfield><subfield code="0">(DE-588)4038270-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Außenhandelspolitik</subfield><subfield code="0">(DE-588)4003841-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="651" ind1=" " ind2="7"><subfield code="a">Entwicklungsländer</subfield><subfield code="0">(DE-588)4014954-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Entwicklungsländer</subfield><subfield code="0">(DE-588)4014954-7</subfield><subfield code="D">g</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Medizinische Versorgung</subfield><subfield code="0">(DE-588)4038270-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Außenhandelspolitik</subfield><subfield code="0">(DE-588)4003841-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="8">1\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Moon, Suerie</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-EBA</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-029198161</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">1\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=504495</subfield><subfield code="l">FAW01</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FAW_PDA_EBA</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=504495</subfield><subfield code="l">FAW02</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FAW_PDA_EBA</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
geographic | Entwicklungsländer (DE-588)4014954-7 gnd |
geographic_facet | Entwicklungsländer |
id | DE-604.BV043787102 |
illustrated | Not Illustrated |
indexdate | 2024-07-10T07:35:08Z |
institution | BVB |
isbn | 9781409426349 1409426343 9781409470908 1409470903 1283901919 9781283901918 9781409426332 1409426335 |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-029198161 |
oclc_num | 828893564 |
open_access_boolean | |
owner | DE-1046 DE-1047 |
owner_facet | DE-1046 DE-1047 |
physical | xviii, 241 pages |
psigel | ZDB-4-EBA ZDB-4-EBA FAW_PDA_EBA |
publishDate | 2013 |
publishDateSearch | 2013 |
publishDateSort | 2013 |
publisher | Ashgate |
record_format | marc |
series2 | Global health |
spelling | Hein, Wolfgang 1949- Verfasser aut Informal norms in global governance human rights, intellectual property rules and access to medicines Wolfgang Hein, Suerie Moon Farnham, Surrey, England Ashgate ©2013 xviii, 241 pages txt rdacontent c rdamedia cr rdacarrier Global health Includes bibliographical references (pages 199-229) and index Cover; Contents; List of Figures and Tables; Foreword; Preface; List of Abbreviations; 1 Introduction; (a) Formal and informal norms in the governance of a global society; (b) The emergence of the "access to medicines" norm; (c) Informal norms and human rights; (d) Overview of the book; 2 Towards a Global Society; (a) Globalization; (b) From international relations to global governance; (c) Transnational actors in global governance; (d) Post-Westphalian global health governance (E) Interfaces, nodal governance, and polylateral diplomacy: Elements of the social construction of global health governance (GHG)(f) Global society, global politics and human rights; 3 Access to Medicines: A Matter of Human Rights; (a) The right to health and to access to essential medicines; (b) Sources of formal and informal norms on access to medicines; (c) The UN Special Rapporteur on the Right to Health; 4 Access to Medicines and Intellectual Property; (a) Medicines and the global public goods problem; (b) Introducing the WTO; (c) Introduction to TRIPS-basic issues (D) TRIPS, TRIPS+ and the fight for social issues5 The HIV/AIDS Crisis: The Rise of the Access Norm; (a) A brief introduction to HIV/AIDS medicines; (b) AIDS treatment and IP rules in the developing world: The special role of Brazil; (c) A window of opportunity: The 1999-2001 "policy crisis"; (d) The Doha Declaration on the TRIPS Agreement and Public Health; (e) Early debates on disease scope: The WTO medicines (6) decision and the TRIPS amendment; (f) Improved access to medicines: Using TRIPS flexibilities; (g) The first developing country compulsory licenses: Zimbabwe and Malaysia (H) Thailand: Regularizing the use of compulsory licensing(i) Role and character of finance for treatment; (j) The rise of access to medicines: Timeline of decisions and increased use of compulsory licensing, 2001-2010; 6 Beyond HIV in Africa: Solidification and Expansion of the Access Norm; (a) Solidification of the access norm; (b) Inclusiveness of the access norm: Which medicines are essential?; (c) The inclusiveness of the access norm: Middle-income countries as the new battlefield?; 7 Challenges to the Stability of Informal Norms; (a) Challenges in access to HIV/AIDS medicines (B) Free trade agreements(c) WTO accession agreements; (d) Alternate channels for IP rulemaking; 8 Re-framing the Access Norm: Incorporating Innovation; (a) From expert commissions to global strategies; (b) Innovation and access: I+A; (c) Changing expectations for the MICs: Contributions to R & D; 9 The Impact of Non-state Actors on Informal Norms: Nodal Governance and Global Democracy; (a) Nodal governance and informal norm-building; (b) Nodal governance: Interfaces between IGOs, governments and non-state actors in global politics; (c) Role and power of non-state actors in global norm-building Hein and Moon take up a serious problem of contemporary global governance: what can be done when international trade rules prevent the realization of basic human rights? This book recounts the remarkable story of the access to medicines movement and offers an explanation for how the "access norm" emerged against long odds. It also explores the stability and scope of the norm with respect to other diseases and emerging economies. Finally, in light of the high barriers to changing formal global trade rules, the book considers the potential and limitations of informal norms for protecting human r Public Health Developing Countries Human Rights International Cooperation Patents as Topic Pharmaceutical Preparations / economics Drugs / Prices / Developing countries Foreign trade regulation / Developing countries Patents (International law) Public health / International cooperation Right to health / Developing countries HEALTH & FITNESS / Diseases / General bisacsh HEALTH & FITNESS / Health Care Issues bisacsh MEDICAL / Diseases bisacsh MEDICAL / Health Care Delivery bisacsh MEDICAL / Health Policy bisacsh MEDICAL / Public Health bisacsh SOCIAL SCIENCE / Disease & Health Issues bisacsh Drugs / Prices fast Foreign trade regulation fast Patents (International law) fast Public health / International cooperation fast Right to health fast Entwicklungsländer Medizin Public health International cooperation Right to health Developing countries Drugs Prices Developing countries Foreign trade regulation Developing countries Medizinische Versorgung (DE-588)4038270-9 gnd rswk-swf Außenhandelspolitik (DE-588)4003841-5 gnd rswk-swf Entwicklungsländer (DE-588)4014954-7 gnd rswk-swf Entwicklungsländer (DE-588)4014954-7 g Medizinische Versorgung (DE-588)4038270-9 s Außenhandelspolitik (DE-588)4003841-5 s 1\p DE-604 Moon, Suerie Sonstige oth 1\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk |
spellingShingle | Hein, Wolfgang 1949- Informal norms in global governance human rights, intellectual property rules and access to medicines Public Health Developing Countries Human Rights International Cooperation Patents as Topic Pharmaceutical Preparations / economics Drugs / Prices / Developing countries Foreign trade regulation / Developing countries Patents (International law) Public health / International cooperation Right to health / Developing countries HEALTH & FITNESS / Diseases / General bisacsh HEALTH & FITNESS / Health Care Issues bisacsh MEDICAL / Diseases bisacsh MEDICAL / Health Care Delivery bisacsh MEDICAL / Health Policy bisacsh MEDICAL / Public Health bisacsh SOCIAL SCIENCE / Disease & Health Issues bisacsh Drugs / Prices fast Foreign trade regulation fast Patents (International law) fast Public health / International cooperation fast Right to health fast Entwicklungsländer Medizin Public health International cooperation Right to health Developing countries Drugs Prices Developing countries Foreign trade regulation Developing countries Medizinische Versorgung (DE-588)4038270-9 gnd Außenhandelspolitik (DE-588)4003841-5 gnd |
subject_GND | (DE-588)4038270-9 (DE-588)4003841-5 (DE-588)4014954-7 |
title | Informal norms in global governance human rights, intellectual property rules and access to medicines |
title_auth | Informal norms in global governance human rights, intellectual property rules and access to medicines |
title_exact_search | Informal norms in global governance human rights, intellectual property rules and access to medicines |
title_full | Informal norms in global governance human rights, intellectual property rules and access to medicines Wolfgang Hein, Suerie Moon |
title_fullStr | Informal norms in global governance human rights, intellectual property rules and access to medicines Wolfgang Hein, Suerie Moon |
title_full_unstemmed | Informal norms in global governance human rights, intellectual property rules and access to medicines Wolfgang Hein, Suerie Moon |
title_short | Informal norms in global governance |
title_sort | informal norms in global governance human rights intellectual property rules and access to medicines |
title_sub | human rights, intellectual property rules and access to medicines |
topic | Public Health Developing Countries Human Rights International Cooperation Patents as Topic Pharmaceutical Preparations / economics Drugs / Prices / Developing countries Foreign trade regulation / Developing countries Patents (International law) Public health / International cooperation Right to health / Developing countries HEALTH & FITNESS / Diseases / General bisacsh HEALTH & FITNESS / Health Care Issues bisacsh MEDICAL / Diseases bisacsh MEDICAL / Health Care Delivery bisacsh MEDICAL / Health Policy bisacsh MEDICAL / Public Health bisacsh SOCIAL SCIENCE / Disease & Health Issues bisacsh Drugs / Prices fast Foreign trade regulation fast Patents (International law) fast Public health / International cooperation fast Right to health fast Entwicklungsländer Medizin Public health International cooperation Right to health Developing countries Drugs Prices Developing countries Foreign trade regulation Developing countries Medizinische Versorgung (DE-588)4038270-9 gnd Außenhandelspolitik (DE-588)4003841-5 gnd |
topic_facet | Public Health Developing Countries Human Rights International Cooperation Patents as Topic Pharmaceutical Preparations / economics Drugs / Prices / Developing countries Foreign trade regulation / Developing countries Patents (International law) Public health / International cooperation Right to health / Developing countries HEALTH & FITNESS / Diseases / General HEALTH & FITNESS / Health Care Issues MEDICAL / Diseases MEDICAL / Health Care Delivery MEDICAL / Health Policy MEDICAL / Public Health SOCIAL SCIENCE / Disease & Health Issues Drugs / Prices Foreign trade regulation Right to health Entwicklungsländer Medizin Public health International cooperation Right to health Developing countries Drugs Prices Developing countries Foreign trade regulation Developing countries Medizinische Versorgung Außenhandelspolitik |
work_keys_str_mv | AT heinwolfgang informalnormsinglobalgovernancehumanrightsintellectualpropertyrulesandaccesstomedicines AT moonsuerie informalnormsinglobalgovernancehumanrightsintellectualpropertyrulesandaccesstomedicines |